Magnesium hydroxide 415 mg per 5 mL Oral Suspension
RxNorm 104015
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 104015 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: magnesium hydroxide 415 mg per 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Magnesium hydroxide 83 mg/ML Oral Suspension
(Atom ID: 12335860)
SY
Synonym (SY):
Magnesium hydroxide 415 mg per 5 mL Oral Suspension
(Atom ID: 2992857)
PT
Designated preferred name (PT):
Magnesium hydroxide 83 mg/mL oral suspension
(Atom ID: 10301218)
FN
Full form of descriptor (FN):
Product containing precisely magnesium hydroxide 83 mg/1 mL conventional release oral suspension (clinical drug)
(Atom ID: 10314455)
Patient Education
Magnesium Hydroxide
Magnesium hydroxide is used to treat occasional constipation in children and adults on a short-term basis. Magnesium hydroxide is in a class of medications called saline laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.
[Learn More]
* Please review the disclaimer below.